Literature DB >> 19284982

Engineering, cloning, and functional characterization of recombinant LIM mineralization protein-1 containing an N-terminal HIV-derived membrane transduction domain.

Sreedhara Sangadala1, Motohiro Okada, Yunshan Liu, Manjula Viggeswarapu, Louisa Titus, Scott D Boden.   

Abstract

Short peptide sequences known as protein transduction domains have become increasingly prevalent as tools to internalize molecules that would otherwise remain extracellular. Here, we determine whether a purified recombinant mammalian intracellular osteogenic factor delivered by a HIV-derived TAT-peptide tag is indeed capable of intracellular localization in a form accessible to interaction with other proteins. We engineered and bacterially expressed a TAT-fusion-cDNA construct of a known osteogenic factor, LIM mineralization protein-1 (LMP-1) involved in the bone morphogenetic protein (BMP) pathway that has the potential to serve as an enhancer of BMP-2 efficacy. The expressed recombinant protein contains an N-terminal (His)(6)-tag, a hemagglutinin(HA)-tag, and an 11-amino acid HIV-derived TAT-membrane transduction domain and was purified to homogeneity by Sephacryl S-100 molecular exclusion and Ni(2+)-affinity chromatography. The purified TAT-LMP-1 protein was chemically labeled with fluorescein, and its time and concentration dependent entry into rabbit blood cells was monitored by flow cytometry. We demonstrate the accumulation of TAT-tagged LMP-1 both in cytoplasmic and nuclear compartments. By performing affinity pull-down assays, we confirm our earlier findings that the recombinant TAT-LMP-1, when used as molecular bait to identify the intracellular binding proteins, interacts with Smurf1, a known binding partner of LMP-1. We also show potentiation of BMP-2 activity using the purified TAT-LMP-1 in mouse muscle C2C12 cells by assaying a heterologous luciferase-reporter construct containing multiple copies of a BMP-responsive sequence motif. Finally, we also confirm the biological activity of the purified TAT-LMP-1 by showing enhancement of BMP-2 induced increase of alkaline phosphatase mRNA and protein by RT-PCR and enzyme activity, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19284982     DOI: 10.1016/j.pep.2009.01.006

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  5 in total

1.  Characterization of a unique motif in LIM mineralization protein-1 that interacts with jun activation-domain-binding protein 1.

Authors:  Sreedhara Sangadala; Katsuhito Yoshioka; Yoshio Enyo; Yunshan Liu; Louisa Titus; Scott D Boden
Journal:  Mol Cell Biochem       Date:  2014-01       Impact factor: 3.396

2.  A synthetic compound that potentiates bone morphogenetic protein-2-induced transdifferentiation of myoblasts into the osteoblastic phenotype.

Authors:  Satoshi Kato; Sreedhara Sangadala; Katsuro Tomita; Louisa Titus; Scott D Boden
Journal:  Mol Cell Biochem       Date:  2010-11-26       Impact factor: 3.396

3.  Osteoinductive LIM mineralization protein-1 suppresses activation of NF-kappaB and selectively regulates MAPK pathways in pre-osteoclasts.

Authors:  Hui Liu; Maggie Bargouti; Susu Zughaier; Zhaomin Zheng; Yunshan Liu; Sreedhara Sangadala; Scott D Boden; Louisa Titus
Journal:  Bone       Date:  2009-11-18       Impact factor: 4.398

4.  Development and optimization of a cell-based assay for the selection of synthetic compounds that potentiate bone morphogenetic protein-2 activity.

Authors:  Motohiro Okada; Sreedhara Sangadala; Yunshan Liu; Munehito Yoshida; Boojala Vijay B Reddy; Louisa Titus; Scott D Boden
Journal:  Cell Biochem Funct       Date:  2009-12       Impact factor: 3.685

Review 5.  BMP and Beyond: A 25-Year Historical Review of Translational Spine Research at Emory University.

Authors:  Steven Presciutti; Scott Boden
Journal:  Spine Surg Relat Res       Date:  2018-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.